90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.

scientific article published on 24 October 2013

90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1017114460
P356DOI10.1186/1742-4690-10-111
P932PMC publication ID3827937
P698PubMed publication ID24156545
P5875ResearchGate publication ID258042255

P50authorFrank KirchhoffQ15451512
Christine GoffinetQ79511859
Daniela KrnavekQ125316562
Veronika LodermeyerQ125316600
P2093author name stringTanja Waldmann
Jan Münch
Christina M Stürzel
Christian Dietz
Christian Kolbe
Kristina Suhr
Nicola Schrott
P2860cites workFew and far between: how HIV may be evading antibody avidityQ21090507
The secreted tumor-associated antigen 90K is a potent immune stimulatorQ24314376
Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domainQ24316043
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 proteinQ24635842
Cyclophilin C-associated protein: a normal secreted glycoprotein that down-modulates endotoxin and proinflammatory responses in vivoQ24672890
The cyclophilinsQ24812580
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinQ27860488
Functional studies on recombinant domains of Mac-2-binding proteinQ28203993
Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesionQ28290516
Tetherin inhibits retrovirus release and is antagonized by HIV-1 VpuQ29547836
The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu proteinQ29619540
SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.Q30421200
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individualsQ33535874
Dissecting interferon-induced transcriptional programs in human peripheral blood cellsQ33546362
Multiple blocks to human immunodeficiency virus type 1 replication in rodent cellsQ33603453
CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infectionQ33826740
Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cellsQ34120302
Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteinsQ34123672
Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteinsQ34332728
The SRCR superfamily: a family reminiscent of the Ig superfamilyQ34338190
Effects of IFN alpha on late stages of HIV-1 replication cycleQ34484926
Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomasQ35063118
Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffectedQ35076987
HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporationQ35113720
HIV Restriction Factors and Mechanisms of EvasionQ35902681
Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease.Q35975990
Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120Q36687567
Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivoQ37256641
Monoclonal antibodies specific for human tumor-associated antigen 90K/Mac-2 binding protein: tools to examine protein conformation and functionQ38313181
Anti-HIV state but not apoptosis depends on IFN signature in CD4+ T cellsQ38883638
Human immunodeficiency virus type 1 envelope proteins traffic toward virion assembly sites via a TBC1D20/Rab1-regulated pathway.Q39409784
Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfectionQ39593653
Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissueQ39751463
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kineticsQ40211546
Isolation and functional characterization of the human 90K promoterQ42817120
Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected childrenQ43738629
90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection.Q45780008
Lipoprotein 90K in human immunodeficiency virus-infected patients: a further serologic marker of progressionQ45854416
Unusually high level of a tumor-associated antigen in the serum of human immunodeficiency virus-seropositive individualsQ45854590
Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patientsQ45873509
A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.Q53831094
Domain organization of Mac-2 binding protein and its oligomerization to linear and ring-like structuresQ56918500
Lack of mother-to-child HIV-1 transmission is associated with elevated serum levels of 90 K immune modulatory proteinQ63413191
Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infectionsQ63413197
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cellsQ63413202
Recombinant human leukocyte interferon-alpha 2b stimulates the synthesis and release of a 90K tumor-associated antigen in human breast cancer cellsQ68467544
Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancerQ68871731
Identification of a novel serum protein secreted by lung carcinoma cellsQ68882683
90K (Mac-2 BP) in human milkQ73215690
P921main subjectinfectivityQ1662346
P304page(s)111
P577publication date2013-10-24
P1433published inRetrovirologyQ15793508
P1476title90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1
P478volume10

Reverse relations

cites work (P2860)
Q91800366A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
Q59791100A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV
Q36086989Antiviral gene expression in psoriasis
Q38671133Cellular Antiviral Factors that Target Particle Infectivity of HIV-1
Q90616835Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor
Q40640876Guanylate binding protein 5: Impairing virion infectivity by targeting retroviral envelope glycoproteins
Q64972531HIV-1 Envelope Glycoprotein at the Interface of Host Restriction and Virus Evasion.
Q30369227Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs
Q47550785Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane
Q47552023Interferons and beyond: Induction of antiretroviral restriction factors
Q39748338KNIME for Open-Source Bioimage Analysis: A Tutorial
Q37239856M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner
Q47555946Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature
Q39419975Role of Innate Genes in HIV Replication
Q54216802The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K is Species-Specific.
Q92734574Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression

Search more.